Schedule 13D ownership disclosure
Strongbridge Biopharma plc
Security class unavailable · CUSIP: G85347105
Event date: 2015-10-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000795
- Form type
- SC 13D
- Filer
- Growth Equity Opportunities Fund III, LLC
- CIK
- CIK 1551055
- Filed
- May 18, 2016
- Reporting period
- Oct 21, 2015
- Description
- Schedule 13D beneficial ownership